B. Braun SE: Ingrun Alsleben appointed to the Executive Board

"I am delighted that with Ingrun Alsleben we have been able to recruit an exceptionally accomplished and internationally experienced financial expert and leader to the B. Braun SE Management Board. Mrs. Alsleben is just as familiar with successful transformation processes as she is with different cultural requirements - both are very valuable for B. Braun. As far as Dr. Annette Beller is concerned, she has played a formative role in shaping the development of the B. Braun Group for almost three decades with her outstanding knowledge of finance, tax and business operations. She will continue to contribute her wealth of experience in the coming months, thus enabling a seamless transition in the finance department," says Prof. Dr. Thomas Rödder, Chairman of the Supervisory Board of B. Braun SE.

Ingrun Alsleben has 26 years of international experience in various areas of finance in the Bayer Group. In China, she headed, among other things, the Planning and Controlling and Finance and Accounting departments of the HealthCare division and spent around seven years as CFO for Bayer in Hong Kong. This was followed by positions as the person responsible for Latin America, Africa, the Middle East, the APAC region and as CFO in Italy until she took up her current position in 2021.

Ingrun Alsleben is an economist and studied at Leibniz University in Hanover.